R. Geoffrey Sargent
Founder at GENETETHER THERAPEUTICS INC.
Net worth: 19 375 $ as of 30/05/2024
R. Geoffrey Sargent active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENETETHER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 11/02/2018 | - |
| Founder | 11/02/2018 | - | |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Director/Board Member | 31/01/2021 | - |
| Chief Tech/Sci/R&D Officer | 31/01/2021 | - | |
| Founder | 11/02/2018 | - | |
| Chief Executive Officer | 11/02/2018 | 31/01/2021 | |
| President | 11/02/2018 | 31/01/2021 |
Career history of R. Geoffrey Sargent
Former positions of R. Geoffrey Sargent
| Companies | Position | Start | End |
|---|---|---|---|
Onconetics Pharmaceuticals, Inc.
 Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Chief Tech/Sci/R&D Officer | 31/07/2017 | 28/02/2018 |
Training of R. Geoffrey Sargent
| Georgia Institute of Technology | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Statistics
International
| United States | 5 |
| 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Onconetics Pharmaceuticals, Inc.
Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
| GeneTether Therapeutics, Inc. |
- Stock Market
- Insiders
- R. Geoffrey Sargent
- Experience